General Information of the Compound
| Compound ID |
CP0545949
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R)-8-(4-fluorophenyl)-N,5-dimethyl-1-methylsulfonyl-3-oxo-4,5-dihydro-2H-furo[3,2-h][1,4]benzodiazepine-7-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H20FN3O5S
|
||||||||||||||||||
| Molecular Weight |
445.472
|
||||||||||||||||||
| Canonical SMILES |
CNC(=O)c1c(oc2cc3N(CC(=O)N[C@H](C)c3cc12)S(C)(=O)=O)-c1ccc(F)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H20FN3O5S/c1-11-14-8-15-17(9-16(14)25(31(3,28)29)10-18(26)24-11)30-20(19(15)21(27)23-2)12-4-6-13(22)7-5-12/h4-9,11H,10H2,1-3H3,(H,23,27)(H,24,26)/t11-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QVYDSTSPZGBXPN-LLVKDONJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00149, Nonstructural protein 5A
Protein ID: PT00013, RNA-directed RNA polymerase